Status:
ACTIVE_NOT_RECRUITING
Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study)
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Psoriasis
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
The purpose of this research study is to determine the efficacy of TENS therapy in reducing the pain experienced by patients during and after the injection of biological medications. The study team is...
Detailed Description
A total of 10-20 subjects at one research site will be recruited to participate, specifically, individuals who receive the injection of medication in two separate sites. The inclusion criteria will be...
Eligibility Criteria
Inclusion
- Subject has a diagnosis of psoriasis and receiving biologic medication injection in two sites during their clinic visit as part of their management.
- Subject is 18 years of age or older.
- Subject has a working knowledge of English.
Exclusion
- Subject not receiving biologic medication injection.
- Subject under 18 years of age.
- Subject does not have a working knowledge of English.
Key Trial Info
Start Date :
August 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04058652
Start Date
August 7 2019
End Date
December 1 2026
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157